Journal of Dental Medicine

---

Normal 0 false false false EN-US X-NONE AR-SA Two Root coverage methods of free gingival graft method (FGG) and coronally positioned flap (CPF) by using citric acid were evaluated in anterior mandibular labial site of 16 patients. The measurements were done before first FGG surgery, after FGG and two months following the second surgery. The results showed 1% improvement of root coverage after surgery while in two stage CPF method by using citric acid, significant effect of citric acid was obtained. The width of Keratinized gingiva changed to 6.25mm from 1.18mm which was statistically significant.

---

Statement of Problem: Chronic periodontitis is one of the most prevalent periodontal diseases in the world which may be treated through surgical or non-surgical approaches.
Purpose: The aim of this study was to compare the efficacy of Doxycycline and placebo following SRP in non-surgical treatment of chronic periodontitis.
Materials and Methods: This double blind interventional study was conducted on patients attended to the periodontology department of Tehran faculty of dentistry from 2002 to 2003. After SRP, 22 cases and 23 controls were received Doxycycline and placebo, 20 mg twice a day for 3 months, respectively. Bleeding on probing (BOP), pocket depth (PD)<6mm and PD>7mm, and also clinical attachment level (CAL)<6mm and CAL>7mm in cases and controls after 3 and 6 months were compared by student t-test.Results: BOP after 3 and 6 months in Doxycycline recipients following SRP were significantly lower than in placebo recipients (P^0.007 and P=0.045 respectively). PD<6mm, PD>7mm, CAL<6mm and CAL>7mm in 3 and 6 months after SRP in cases were much lower than controls.
Conclusion: This study showed that the administration of Doxycycline for 3 months after SRP resulted in improvement of clinical indices as compared with SRP alone. Therefore, Doxycycline administration is recommended for chronic periodontitis treatment after SRP.

---

Background and Aim: Intrabony periodontal defects are important problems in periodontology and up to now several ways have been suggested for their treatment .Treatment with enamel matrix derivatives (EMD) has been shown to enhance periodontal regeneration. There is limited information available from clinical trials regarding the performance of EMD in the treatment of periodontal intrabony defects. This study was designed to compare the clinical and radiographic effects of EMD treatment to that of open flap debridment (OFD) for two and three walled intrabony defects.

Materials and Methods: 18 patients were included in this clinical trial which have 24 two and/ or three intrabony defects. Defects were randomly divided into two groups (test and control). Defects in test group were treated with flap surgery plus EMD and in control group with open flap debridment. At baseline and at 3 and 6 months follow up, clinical and radiographic measurements were performed. Data were analyzed using Greenhouse-Geisser test with p<0.05 as the limit of significance.

Results: At 3 and 6 months, mean probing pocket depth reduction was greater in the test group (EMD) (4.33 mm and 4.70 mm) compared to the OFD group (2.54 mm and 3.09 mm). Mean values for clinical attachment gain in the EMD group after 3 and 6 months were 4.29 mm and 4.98 mm, and in OFD group were 2.83 and 2.82 mm respectively. Radiographic bone gain measured by radiovisiography technique was greater in the EMD group compared to the OFD group (4.66 mm in EMD and 1.11 mm in OFD group after 3 months and 5.78 mm in EMD and 1.39 mm in OFD group after 6 months).

Conclusion: Based on the results of this study, treatment with flap surgery and EMD compared to open flap debridment, produced more favorable clinical improvements in two and three walled intrabony defects.

---

Background and Aim: Root filling materials are usually in close contact with living tissues. So their biological properties like mutagenicity and cytotoxicity are important. These properties help us determine the potential damage to periapical tissues, or potential DNA mutations, and malignant transformation of the cells. The aim of this study was to evaluate the mutagenicity and cytotoxicity of four root canal sealers: AH Plus (Dentsply, DeTrey), Ketac-Endo Aplicap (3M ESPE), Sankin Apatite III (Sankin K.K), and Tubli-Seal EWT (Kerr).

Materials and Methods: In this experimental in vitro study fresh and set specimens from AH Plus, Ketac-Endo Aplicap, Sankin Apatite III, and Tubli-Seal EWT were immersed in culture medium for 1, 2 and 7 days. Cytotoxicity was assessed using tetrazolium bromide reduction assay (MTT) after 1, 2 and 7 days exposure of diluted extracts to L929 cells. Extracts of sealers in phosphate buffer saline (PBS) were used to examine the mutagenic effects by sos-umu test according to standard procedures. Data were analyzed using one way ANOVA, Kruskall Wallis, Mann Whitney and Post hoc tests with P<0.05 as the level of significance.

Results: Extracts of all freshly mixed sealers were cytotoxic. Ketac-Endo Aplicap and Sankin Apatite III showed the lowest toxicity respectively and Tubli-Seal EWT the highest. In contrast to other sealers, the cytotoxicity of Tubli-Seal showed no decrease with time. -galactosidase did not increase significantly thus none of the sealers showed mutagenic effects.

Conclusion: Based on the results of this study, Tubli-Seal EWT showed the highest cytotoxicity with time. Other sealers showed decreasing cytotoxicity with time. No mutagenicity effects was observed in none of  tested materials.

---

  Background and Aims: The purpose of the present study was to review the studies regarding serological and salivary oxidant / antioxidant status in patients with recurrent aphthous stomatitis (RAS).

  Materials and Methods: The literature was searched using key words RAS, Antioxidants, Saliva, Hematinic (s) and Hematinic Acid in the last 10 years, particularly the recent 3 years (2010-2013). At total of 37 clinical trials, 18 case-control articles were selected and evaluated fulfilling the requirements as the RAS patients having at least 3 oral aphthous attack per year. The exclusion criteria included systemic as well as periodontal diseases, iron deficiency associated anemia, medication usage and smoking.

  Conclusion: Almost all lipid-peroxidation studies in serum and saliva were manifested by an increase of malondialdehyde (MDA) concentration in RAS patients compared with controls. This would indicate the role of reactive oxygen species (ROS) in the etiology of the disease. Serum trace elements (Zn, Se) were reduced and Cu was increased in RAS patients in comparison with control individuals. A decreased serum superoxide dismutase (SOD) and an increased salivary SOD were observed in all RAS patients. Catalase (CAT) and uric acid (UA) analyses were non-inclusive. Levels of paraoxonase and arylesterase as well as antioxidant vitamins (A, E, C) were lower in RAS patients than that of controls.